Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K+ channels activation

Life Sciences

Volumn 74, Issue 20, 2004, Pages 2577-2591

  Alves, Daniela P ^a   Tatsuo, Maria A F ^a   Leite, Romulo ^a   Duarte, Igor D G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antinociception; Diclofenac; K+ channel blockers; K+ channels

Indexed keywords

4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CARRAGEENAN; CESIUM; CHARYBDOTOXIN; CYCLIC GMP; DEQUALINIUM; DIAZOXIDE; DICLOFENAC; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; INDOMETACIN; METHYLENE BLUE; N(G) NITROARGININE; NALOXONE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE RECEPTOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; TETRYLAMMONIUM; TOLBUTAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; EXPERIMENTAL TEST; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; RAT;

ANALGESIA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLYBURIDE; HYPERALGESIA; INDOMETHACIN; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; TOLBUTAMIDE;

EID: 1542358720     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.10.012     Document Type: Article

References (41)

1. Ahn D.K., Kim Y.S., Park J.S. Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats. Neurosciences Letter. 243:1998;105-108.
2. + channels in the peripheral antinociceptive effect induced by dypirone. European Journal of Pharmacology. 444:2002;47-52.
3. + channels. Science. 247:1990;852-854.
4. Attal N., Kayser V., Eshalier A., Benoist J.M., Guilbaud G. Behavioral and electrophysiological evidence for an analgesic effect of a non-steroidal anti-inflammatory agent, sodium diclofenac. Pain. 35:1988;341-348.
5. Björkman R., Hedner J., Hedner T., Henning M. Central, naloxone-reversible antinociception by diclofenac in the rat. Naunyn Schmiedeberg's Archives of Pharmacology. 342:1990;171-176.
6. Brogden R.N., Heel R.C., Pakes G.E., Speight T.M., Avery G.S. Diclofenac sodium: A review of its pharmacological properties and therapeutics use in rheumatic diseases and pain of varying origin. Drugs. 20:1980;24-48.
7. + channels. American Journal of Physiology. 273:1997;H76-H83.
8. Cook N.S., Quast U. Potassium channel pharmacology. Cook N.S. Potassium channels: Structure, classification, function, and therapeutic potential. 1990;181-255 Ellis Horwood Limited, Chichester.
9. Duarte I.D.G., Dos Santos I.R., Lorenzetti B.B., Ferreira S.H. Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. European Journal of Pharmacology. 217:1992;225-227.
10. Duarte I.D.G., Ferreira S.H. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. European Journal of Pharmacology. 321:1992;171-174.
11. Duarte I.D.G., Lorenzetti B.B., Ferreira S.H. Peripheral analgesia and activation of the nitric oxide cyclic GMP pathway. European Journal of Pharmacology. 186:1990;289-293.
12. Dunn P.M. Dequalinium, a selective blocker of the slow afterhyperpolarization in rat sympathetic neurones in culture. European Journal of Pharmacology. 252:1994;189-194.
13. + channels. Annual Review of Pharmacology and Toxicology. 33:1993;597-637.
14. Ferreira S.H. Prostaglandins, aspirin like drugs and analgesia. Nature (New Biol). 240:1972;200-203.
15. Ferreira S.H., Duarte I.D.G., Lorenzetti B.B. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. European Journal of Pharmacology. 201:1991;121-122.
16. ++ dependent process. Prostaglandins. 18:1979;179-190.
17. Germany A., Gonzales P., Contreras E. Possible role of nitric oxide in the antinociceptive action of intraventricular bradykinin in mice. European Journal of Pharmacology. 310:1996;123-127.
18. Granados-Soto V., Argülles C.F., Ortiz M.I. The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels. Neuropharmacology. 43:2002;917-923.
19. + channel in cultured vascular smooth muscle cells. Circulation research. 74:1994;470-476.
20. Lázaro-Ibáñez G.G., Torres-López J.E., Granados-Soto V. Participation of the nitric oxide-cyclic GMP-ATP-sensitive K+ channel pathway in the antinociceptive action of ketorolac. European Journal of Pharmacology. 426:2001;39-44.
21. Malmberg A.B., Yaksh T.L. Antinociceptive actions of spinal nonsteroidal antiinflammatory agents on the formalin test in the rat. Journal of Pharmacology and Experimental Therapeutics. 263:1992;136-139.
22. Martini A., Bondiolloti G.P., Sacerdote P., Pierro L., Picotti G.B., Panerai A.E., Restelli L., Zancaner F., Monza G. Diclofenac increases beta endorphin plasma concentrations. The Journal of International Medical Research. 12:1984;92-95.
23. Menasse R., Hedwell P.R., Kraetz J., Perlein C., Riesterer L., Sallman A., Ziel R., Jaques R. Pharmacological properties of diclofenac sodium and its metabolites. Scandinavian Journal of Rheumatology supplement. 22:1978;5-16.
24. + channels from mammalian skeletal muscle. Nature. 313:1985;316-318.
25. + channels. Journal of Physiology. 486:1995;47-58.
26. + channels in the cardiovascular system. American Journal of Physiology. 261:1991;H1675-H1690.
27. 2-adrenoceptor, GABA B and k-opioid receptor agonists. British Journal of Pharmacology. 110:1993;1049-1054.
28. + channel-acting drugs. British Journal of Pharmacology. 114:1995;1296-1302.
29. 2: Effects of analgesic drugs on hyperalgesia. Journal of Pharmacobio-Dynamics. 9:1986;902-908.
30. Ortiz M.I., Torres-López J.E., Castañeda-Hernández G., Rosas R., Vidal-Cantú G.C., Granados-Soto V. Pharmacological evidence for the activation of K+ channels by diclofenac. European Journal of Pharmacology. 438:2002;85-91.
31. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissues. Archives Internationales de Pharmacodynamie et de Therapie. 111:1957;409-419.
32. + channels. British Journal of Pharmacology. 129:2000;110-114.
33. Sacerdote P., Monza G., Mantegazza P., Panerai A.E. Diclofenac and pirprofen modify pituitary and hypothalamic beta endorphin concentrations. Pharmacological research communications. 17:1985;679-684.
34. + channels and block neurosecretion. Proceedings of National Academy of Sciences of USA. 87:1990;3489-3492.
35. 2-induced hyperalgesic paw. British Journal of Pharmacology. 134:2001;127-131.
36. + channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. European Journal of Pharmacology. 400:2000;67-71.
37. Stein C. Peripheral mechanisms of opioid analgesia. Anesthesia and Analgesia. 76:1993;182-191.
38. Thornbury K.D., Ward S.M., Dalziel H.H., Carl A., Westfall D.P., Sanders K.M. Nitric oxide and nitrocysteine mimic nonadrenergic, noncholinergic hyperpolarization in canine proximal colon. American Journal of Physiology. 26:1991;G553-G557.
39. Tonussi C.R., Ferreira S.H. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. European Journal of Pharmacology. 251:1994;173-179.
40. Vivancos G.G., Parada C.A., Ferreira S.H. Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues. British Journal of Pharmacology. 138:2003;1351-1357.
41. + channel in hypothalamic gamma-aminobutyric acid neurons: pharmacology, estrogen sensitivity, and relevance to the control of the reproductive axis. Journal of Pharmacology and Experimental Therapeutics. 299:2001;21-30.